SLP - Buy Johnson & Johnson Dividend King With Steady Growing Defensive Earnings
Johnson & Johnson (JNJ) is a buy for the dividend growth investor. Johnson & Johnson is one of the largest manufacturers and distributors of medical products and pharmaceuticals. JNJ is a conservative investment that should be in all portfolios, being defensive when the market and economy are weak. The 57th dividend increase in a row was declared in April 2019 for an increase from 0.90/Qtr. to 0.95/Qtr. or a 6% increase. One thing I think that is keeping JNJ down is the lawsuits concerning asbestos in their talcum powder. This is overdone giving you a